Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07075939 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Centralization and Oncologic Outcomes in Ovarian Cancer

Study acronym: COOC - REMO
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study completion pushed from Jun 2030 to Jun 2031
    • Site details revised at 2 of 7 sites
    v3
  2. Trial status: Active, Not Recruiting to Recruiting
    • Site details revised at 7 of 7 sites
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a multicenter, observational, retrospective and prospective study conducted within the REMO (Reggio Emilia - Modena) network in the Emilia-Romagna region (Italy), promoted by AUSL-IRCCS of Reggio Emilia. The study aims to evaluate the impact of surgical centralization and treatment strategies adopted during the COVID-19 pandemic on oncologic outcomes in patients diagnosed with the epithelial ovarian cancer (EOC) from 2018 to 2023. The retrospective component includes patients treated between 2018 and 2023, while the prospective component consists of clinical follow-up of those patients over the next five years.
Trial Details
NCT Number NCT07075939
Lead Sponsor Azienda USL Reggio Emilia - IRCCS
Collaborators: AUSL di Modena - Ospedale Ramazzini di Carpi, AUSL di Modena - Ospedale di Mirandola, AUSL di Modena - Ospedale Civile di Sassuolo, AUSL di Modena - Ospedale di Pavullo nel Frignano, AUSL di Modena - Ospedale di Vignola, Azienda Ospedaliero-Universitaria di Modena
Conditions
(from sponsor)		 Epithelial Ovarian Cancer, Ovarian Neoplasms, Advanced Ovarian Cancer
Related terms Carcinoma, Ovarian Epithelial, COVID-19, Ovarian Neoplasms
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov